ReutersAlzheimer's drug study yields positive results, say makers Eisai and BiogenSep 27, 2022Julie Steenhuysen, Rocky Swift & Deena BeasleyBy Julie Steenhuysen, Rocky Swift & Deena Beasleymore_vert
Alzheimer's Research UKNew hope as Alzheimer's drug slows memory decline in phase 3 trialSep 28, 2022more_vert
ReutersBiogen shares soar on landmark Alzheimer's data, lift rivalsSep 28, 2022Manas Mishra & Natalie GroverBy Manas Mishra & Natalie Grovermore_vert
The GuardianSuccess of experimental Alzheimer’s drug hailed as ‘historic moment’Sep 28, 2022Hannah DevlinBy Hannah Devlinmore_vert
The New York TimesAlzheimer's Drug Slows Cognitive Decline in Key Study (Published 2022)Sep 27, 2022Pam Belluck & Rebecca RobbinsBy Pam Belluck & Rebecca Robbinsmore_vert
New ScientistAlzheimer's drug results are promising – but not a major breakthroughSep 28, 2022Clare WilsonBy Clare Wilsonmore_vert
BBC.comAlzheimer's-slowing drug labelled historicSep 28, 2022James GallagherBy James Gallaghermore_vert
NBC NewsAlzheimer's drug slowed progression of the disease in Phase 3 trialSep 28, 2022Berkeley Lovelace & Berkeley Lovelace Jr.By Berkeley Lovelace & Berkeley Lovelace Jr.more_vert